SCHEMBL23083184

SCHEMBL23083184

OCCc1ccc2cccnc2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.49
KDM4E B2RXH2 2/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SUCNR1 Q9BXA5 13/20 0.46
ALDH1A1 P00352 1/20 0.44
OXGR1 Q96P68 2/20 0.40
GMNN O75496 1/20 0.39
TP53 P04637 1/20 0.39
HSP90AA1 P07900 1/20 0.39
MMP2 P08253 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
MMP9 P14780 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
MMP8 P22894 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276117 0.89 SUCNR1 (0.50) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL20517681 0.88 SUCNR1 (0.49) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL3275331 0.85 KDM4E (0.50) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL12895009 0.83 PDE10A (0.49) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL27705784 0.81 PDE10A (0.48) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL28337161 0.81 PDE10A (0.48) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL20156313 0.81 HRH1 (0.50) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL27654114 0.80 PDE10A (0.59) PDE10AKDM4ELMNAALDH1A1GMNN
SCHEMBL12463786 0.80 KDM4E (0.54) PDE10AKDM4ELMNAMEN1KMT2A
SCHEMBL25636448 0.79 SUCNR1 (0.45) PDE10AKDM4ELMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116813938-A Conjugated small molecule modified hydrogel and preparation method thereof 金陵科技学院 2023-09-29 CN claimed
CN-116813938-A Conjugated small molecule modified hydrogel and preparation method thereof 金陵科技学院 2023-09-29 CN disclosed
US-20210069337-A1 INTEGRIN TARGETING LIGANDS AND USES THEREOF SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT 2021-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210069337-A1 INTEGRIN TARGETING LIGANDS AND USES THEREOF ITGAV, ITGA5, ITGB5 PDE10A 4639/4885KDM4E 3001/4885LMNA 1394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.